Faster Launch, Increased Adoption, Higher Revenue, and a Playbook for Commercial Success. Read the white paper.
Download Now
Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Support
  • Client Login
  • Request Demo
  • Prognos Factor®
    • Marketplace
      • Explore & Buy Data
      • Become a Data Provider
  • Products
    • Life Sciences
      • Cohort Designer
      • Patient Journey Software
      • Physician Segmentation
      • Outcomes Insights
      • Alerts
      • Omnichannel Marketing
    • Payers
      • Underwriting Risk Predictor
  • Company
    • Careers
    • News
    • Insights
    • Resources
  • Contact Us
Home Insights Checklist: Helping Life Sciences Choose a RWD Marketplace

Checklist: Helping Life Sciences Choose a RWD Marketplace

  • September 20, 2021
  • Posted in Marketplace

This post was last updated on December 16, 2021 at 3:23 pm

Real-world data (RWD) pharmaceutical marketplaces are on the rise and are transforming the curation and acquisition of patient-level data. 

Prognos Health is the leading digital health data marketplace in the industry and we’ve outlined a brief guide of what to look for when choosing an RWD marketplace for your life sciences organization. A comprehensive list of these features is outlined in the eBook, Accelerate Pharma Value With Marketplace Data Buying. Here ‘s the checklist:

  1. True patient centricity — Select a marketplace that  delivers a sophisticated, yet simple workflow that starts with the patient — not the data source. Prognos Marketplace:

    • Gives users access to explore data by selecting the patient criteria or factors they are interested in (e.g. disease, associated lab tests and prescriptions, comorbidities, etc.)
    • Presents users with the sources within the repository that contain data on those specific patient types. 
  1. Easy linkability — Choose a marketplace that uses a standardized tokenization vendor rather than one with proprietary encryption technology to standardize patient-level data.

    • Prognos partners with the leading health data connectivity vendor, Datavant. 
    • RWD from the Prognos Marketplace will be able to easily integrate with any of the other sources in Datavant’s sizable ecosystem. Streamlining downstream integration in this way saves time and countless resources.The downside of a marketplace that leverages proprietary tokenization is that it will not integrate easily with outside sources that don’t use that same token. 
  1. Deep clinical expertise & guidance — Partner with a marketplace vendor who gives you access to a seasoned network of on-staff clinical experts. 

    • Clinical data, and lab data in particular, is messy and includes both numeric and semantic content and key metrics are often presented in many different ways depending on the data source. 
    • Harmonizing and standardizing data can be a challenge without the appropriate technology and a clinical background. Furthermore, you may find that you require support in ensuring the cohort you build is aligned appropriately with your desired use case
    • Prognos Health’s clinical resources have proven to be valuable collaboration partners when designing patient cohorts, helping you identify the most appropriate clinical criteria and leading you to the best sources of data for your use case. This collaboration can save you time and ensure the accuracy of your data sets. 

These three important differentiators simply scratch the surface of how the Prognos Marketplace outperforms the competition.

Experience the value these and other features can add to your HEOR and Commercial efforts. 
Schedule a discovery call with one of our clinical experts today.

« 5 Benefits of Healthcare Data Marketplaces for Patient-Level RWD
Jumpstart Real World Data Platform Adoption For An Edge Over Life Science Competitors »

Categories

  • AI
  • Alerts
  • Clinical
  • Commercial Launch Excellence
  • Disease Awareness
  • Lab Testing Insights
  • Lab Testing Trends
  • Marketplace
  • Omnichannel Marketing
  • Patient Journey
  • Physician Segmentation
  • Prog Spotlight
  • RWD
  • Technology
  • Underwriting

Archives

Latest Tweets

Prognos HealthFollow

Query billions of fully-integrated lab & health records on more than 325M de-identified patients to answer key healthcare questions in minutes on prognosFACTOR.

Prognos Health
prognosAIPrognos Health@prognosAI·
12 Apr

In our recent panel discussion “How to determine your next best action for every HCP engagement”, leaders from Novartis, GSK, and Takeda Oncology discussed their #RWD strategies to commercialize drug therapies. 3 important best practices were revealed. https://prognoshealth.com/blog/provider-engagement/?utm_source=twitter&utm_medium=social&utm_campaign=provider_engagement_blog

Reply on Twitter 1513876896056057856Retweet on Twitter 1513876896056057856Like on Twitter 1513876896056057856Twitter 1513876896056057856
prognosAIPrognos Health@prognosAI·
7 Apr

68% of #pharma leaders believe the way #lifescience companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help address them.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=rwd_paradigm_shift_blog

#RealWorldData

Reply on Twitter 1512114401360461827Retweet on Twitter 15121144013604618271Like on Twitter 1512114401360461827Twitter 1512114401360461827
prognosAIPrognos Health@prognosAI·
5 Apr

Therapy-related #RWD insights and learnings for a new brand launch can take 12-18 months. One leading #pharma company cut this time in half. Find out how.
https://prognoshealth.com/resource/rwd-analysis/?utm_source=twitter&utm_medium=social&utm_campaign=oncology_case_study

#Omnichannel #Oncology #Pharmaceutical #TherapyLaunch #RealWorldData

Reply on Twitter 1511355425660325897Retweet on Twitter 15113554256603258971Like on Twitter 15113554256603258971Twitter 1511355425660325897
prognosAIPrognos Health@prognosAI·
3 Mar

In a recent survey of #pharma leaders by Reuters, 68% of respondents believe the way #LifeSciences companies currently purchase patient-level data is ripe for disruption.

Find out what challenges dominate current #RWD efforts and how technology can help.

https://prognoshealth.com/blog/real-world-data-pharma-paradigm-shift/?utm_source=twitter&utm_medium=social&utm_campaign=real_world_data_in_pharma_paradigm_shift

Reply on Twitter 1499488030222168066Retweet on Twitter 14994880302221680661Like on Twitter 1499488030222168066Twitter 1499488030222168066
prognosAIPrognos Health@prognosAI·
1 Mar

Dr. Steven Zatz Joins Prognos Health Board of Directors

"Steve’s vision and leadership helped build WebMD into an iconic healthcare brand," says @sundeepbhan1.

https://prognoshealth.com/about-us/news/press-release/dr-steven-zatz-joins-prognos-health-board-of-directors/?utm_source=twitter&utm_medium=social&utm_campaign=dr_zatz_joins_board

Reply on Twitter 1498679196536737795Retweet on Twitter 14986791965367377951Like on Twitter 14986791965367377951Twitter 1498679196536737795
Load More...
  • Prognos Factor®
    • Prognos Marketplace
  • Products
    • Life Sciences
    • Payers
  • Company
    • Insights
    • Careers
    • News
  • LinkedIn
  • Twitter
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2022. All Rights Reserved.

Get Answers Faster

Watch your questions answered with unparalleled speed. De-identified record level patient data already integrated & easily linked to other sources. Prognos puts you in control.

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.